This overexpression might be a compensatory response of GCs that promotes, through the XIST-hsa-miR-193a-3p- PLAU axis, to reduced plasminogen levels and the persistent increase in PAI-1 in FF of PCOS individuals33–35. Here, PLAU is linked to polycystic ovary syndrome.